Robustaflavone

Drug Profile

Robustaflavone

Alternative Names: MCR 125

Latest Information Update: 14 Sep 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator deCODE genetics
  • Class Antivirals
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Hepatitis B

Most Recent Events

  • 15 Apr 2002 MediChem Life Sciences has been acquired by deCODE genetics
  • 22 Jun 2001 Robustaflavone is available for licensing (http://www.medichem.com)
  • 29 Dec 1998 A study of robustaflavone + penciclovir, lamivudine has been added to the antimicrobial activities section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top